Clinical Trial Update: Evaluation Of The Importance Of Risk-Factor Adjustment For Assessing The Relationship Between Voriconazole Utilization And The Development Of Non-Melanoma Skin Cancer Among Lung And Heart/Lung Transplant Patients, 2002-2009g

View source ↗

Summary

This clinical trial update assesses whether adjusting for risk factors changes the observed link between voriconazole use and non-melanoma skin cancer in lung a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Drugs mentioned

• Voriconazole (Vfend) (voriconazole)

Snippet

Sponsor: Pfizer | Conditions: Non-Melanoma Skin Carcinoma | Status: COMPLETED | Results posted: 2013-03-11